Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Pharmacological Ascorbate, Gemcitabine, and Nab-Paclitaxel for Metastatic Pancreatic Cancer (PACMAN 2.1)

NCT02905578 is registered in ClinicalTrials.gov with University of Iowa as lead sponsor.

NCT NCT02905578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02905578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Pharmacological Ascorbate, Gemcitabine, and Nab-Paclitaxel for Metastatic Pancreatic Cancer (PACMAN 2.1)
Lead sponsor
University of Iowa
Phase
Phase 2
Overall status
Completed
Start date
November 28, 2018
Completion date
August 26, 2024
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma, cancer of pancreas, cancer of the pancreas, neoplasms, pancreatic, pancreas cancer, pancreas neoplasms, pancreatic neoplasms